Mice with osteopontin deletion remain predisposed to collagen-induced arthritis
Taeko Ishii MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorShiro Ohshima MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorTetsushi Ishida MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorIchiro Kawase MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorToru Mima MD
Osaka University Graduate School of Medicine and Tokyo Research Laboratories, Tokyo, Japan
Search for more papers by this authorYouichiro Tabunoki BS
Osaka University Graduate School of Medicine and Tokyo Research Laboratories, Tokyo, Japan
Search for more papers by this authorHideyuki Kobayashi PhD
Osaka University Graduate School of Medicine and Tokyo Research Laboratories, Tokyo, Japan
Search for more papers by this authorMasahiro Maeda PhD
Immuno-Biological Laboratories, Gunma, Japan
Search for more papers by this authorLucy Liaw PhD
Maine Medical Center Research Institute, Portland, ME
Search for more papers by this authorNaokazu Kinoshita MD
Osaka-Minami National Hospital, Kawachinagano, Japan
Search for more papers by this authorYukihiko Saeki MD
Osaka University Graduate School of Medicine and Osaka-Minami National Hospital, Kawachinagano, Japan
Search for more papers by this authorTaeko Ishii MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorShiro Ohshima MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorTetsushi Ishida MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorIchiro Kawase MD
Osaka University Graduate School of Medicine, Suita, Japan
Search for more papers by this authorToru Mima MD
Osaka University Graduate School of Medicine and Tokyo Research Laboratories, Tokyo, Japan
Search for more papers by this authorYouichiro Tabunoki BS
Osaka University Graduate School of Medicine and Tokyo Research Laboratories, Tokyo, Japan
Search for more papers by this authorHideyuki Kobayashi PhD
Osaka University Graduate School of Medicine and Tokyo Research Laboratories, Tokyo, Japan
Search for more papers by this authorMasahiro Maeda PhD
Immuno-Biological Laboratories, Gunma, Japan
Search for more papers by this authorLucy Liaw PhD
Maine Medical Center Research Institute, Portland, ME
Search for more papers by this authorNaokazu Kinoshita MD
Osaka-Minami National Hospital, Kawachinagano, Japan
Search for more papers by this authorYukihiko Saeki MD
Osaka University Graduate School of Medicine and Osaka-Minami National Hospital, Kawachinagano, Japan
Search for more papers by this author
REFERENCES
- 1 Rittling SR, Denhardt DT. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 1999; 7: 103–13.
- 2 Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287: 860–4.
- 3 Chabas D, Baranzini SE, Mitchell D, Bernard CCA, Rittling SR, Denhardt DT, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294: 1731–5.
- 4 Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397–440.
- 5 Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Umeshita-Sasai M, et al. Enhanced local production of osteopontin (OPN) in rheumatoid joints. J Rheumatol 2002; 29: 2061–7.
- 6 Ohshima S, Kobayashi H, Yamaguchi N, Nishioka K, Umeshita-Sasai M, Mima T, et al. Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum 2002; 46: 1094–101.
- 7 Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, et al. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci U S A 2002; 99: 4556–61.
- 8 Blom T, Franzen A, Heinegard D, Holmdahl R. Comment on “The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.” Science 2003; 299: 1845.
- 9 Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BLM. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 1998; 101: 1468–78.
- 10 Tada Y, Ho A, Koh DR, Mak TW. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996; 156: 4520–6.
- 11 Kagari T, Doi H, Shimozato T. The importance of IL-1β and TNF-α, and noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 2002; 169: 1459–66.
- 12 Hom JT, Cole H, Estridge T, Gliszcynski VL. Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice. Clin Immunol Immunopathol, 1992; 62: 56–65.
- 13 Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med, 2000; 191: 313–20.
